home.social

#raredisease — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #raredisease, aggregated by home.social.

  1. "AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" doi.org/10.37044/osf.io/e5g6s_

    #biohackathon #ai #MHA26 #rareDisease

    'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." index.biohackrxiv.org/2026/09/

  2. "AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" doi.org/10.37044/osf.io/e5g6s_

    #biohackathon #ai #MHA26 #rareDisease

    'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." index.biohackrxiv.org/2026/09/

  3. "AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" doi.org/10.37044/osf.io/e5g6s_

    #biohackathon #ai #MHA26 #rareDisease

    'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." index.biohackrxiv.org/2026/09/

  4. "AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" doi.org/10.37044/osf.io/e5g6s_

    #biohackathon #ai #MHA26 #rareDisease

    'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." index.biohackrxiv.org/2026/09/

  5. "AI-Assisted Variant Review Across Asia: Country-Level Expert Panels, Regional Collaboration, and Global Knowledge Sharing" doi.org/10.37044/osf.io/e5g6s_

    #biohackathon #ai #MHA26 #rareDisease

    'We argue that the most useful near-term role of artificial intelligence (AI) is not autonomous variant classification, but reducing the friction between distributed evidence and distributed expert judgment. Building on collaborative platform development by participants from institutions in Japan, Singapore, the Philippines, and Thailand, we propose a common workflow connecting variant prioritization and evidence organization, structured expert review, and reviewed-knowledge sharing." index.biohackrxiv.org/2026/09/

  6. 📢 Dr. Haicui Wang erhält Forschungsgelder für den Bau eines 3D-Muskelmodells für zentronukleäre Myopathie, bei dem eine Behandlung mit der CRISPR-Technologie untersucht wird. Mehr Infos 👉 tinyurl.com/37ejbw69

    #ZNM #raredisease #Forschung #ScienceCampusBS #CRISPR

    📷 Zusammen Stark! e.V.

  7. 📢 Dr. Haicui Wang erhält Forschungsgelder für den Bau eines 3D-Muskelmodells für zentronukleäre Myopathie, bei dem eine Behandlung mit der CRISPR-Technologie untersucht wird. Mehr Infos 👉 tinyurl.com/37ejbw69

    #ZNM #raredisease #Forschung #ScienceCampusBS #CRISPR

    📷 Zusammen Stark! e.V.